SpectraA sought compounding after FY23 board-rule lapse

Sep 19, 2026•3 min read

SpectraA Technology Solutions Ltd.

SPECTRAA

Ask Iris

SpectraA sought compounding for failing to appoint independent directors after FY23 turnover reached Rs 100.31 crore, the disclosed trigger for the board requirement. SpectraA appointed three independent directors on October 4, 2025, but its November 24, 2025 application to the Regional Director, South East Region, Hyderabad remained pending.

Why did SpectraA require independent directors?

SpectraA says FY23 turnover of Rs 100.31 crore triggered the independent-director requirement under Sections 149(4) and 149(5) of the Companies Act, 2013, read with Rules 4 and 5 of the Companies (Appointment and Qualification of Directors) Rules, 2014. The company’s application identifies non-appointment of independent directors as the default; it does not dispute either the turnover figure or the resulting statutory requirement.

An independent director is a board member appointed to meet statutory board-composition requirements. The disclosed sequence is therefore a FY23 turnover trigger followed by the October 4, 2025 appointment of three independent directors. SpectraA does not state when the statutory obligation first became due, how long the non-compliance lasted, or the names of the three directors appointed.

The board-composition proceeding is distinct from later operating results. SpectraA reported revenue from operations of Rs 101.1621 crore in FY26, compared with Rs 75.1662 crore in FY25 and Rs 88.9617 crore in FY24; profit after tax was Rs 11.5571 crore in FY26. Those figures show the company’s later scale, while the disclosed independent-director matter is specifically linked to FY23 turnover of Rs 100.31 crore.

What did SpectraA do to address the board-compliance lapse?

SpectraA says it made good the default by appointing three independent directors on October 4, 2025 and filing Form DIR-12 with the Registrar of Companies, Bangalore. Form DIR-12 is used to report appointments and changes involving directors. The company filed its compounding application on November 24, 2025 through the Registrar of Companies with the Regional Director, South East Region, Hyderabad.

Compounding is a process through which an authority may dispose of a specified offence on payment of an amount or subject to its order. It is not an approval that SpectraA had received: the disclosed status of the independent-director matter is pending. The corrective appointment therefore does not itself conclude the regulatory proceeding. SpectraA also says it appointed a company secretary and compliance officer and tightened internal checks and compliance monitoring.

SpectraA disclosed a separate compounding outcome for comparison. Four applications filed on December 1, 2025 concerning delayed DPT-3 returns for FY19 through FY22 were disposed of by a February 14, 2026 order after a total compounding fee of Rs 75,000 was paid on December 26, 2025. DPT-3 is a return under the Companies (Acceptance of Deposits) Rules, 2014, whereas the independent-director proceeding remained pending.

How extensive were SpectraA’s Registrar of Companies filing delays?

SpectraA listed 60 delayed statutory forms or returns spanning events from July 15, 2010 to November 3, 2025, with actual filing dates extending to March 16, 2026. The Registrar of Companies, or ROC, record includes forms on charges, financial statements, annual returns, auditor appointments, share capital, deposits and director changes. SpectraA says the delayed forms were subsequently filed with additional fees where applicable.

The periods of delay differed materially. Two ADT-1 forms for auditor appointments dated August 31 and September 30, 2016 were filed on February 19, 2026. By contrast, an AOC-4 XBRL filing for a September 30, 2024 event was due October 29, 2024 and filed November 30, 2024. AOC-4 concerns financial statements, while XBRL means eXtensible Business Reporting Language, a structured electronic reporting format.

The table’s latest actual filing was Form MGT-14, filed on March 16, 2026 for a March 13, 2023 event due on April 11, 2023. MGT-14 is used to file specified resolutions and agreements with the ROC. SpectraA also identified an MR-1 filing for a November 1, 2025 event, due December 30, 2025 and filed March 12, 2026.

SpectraA characterises the identified non-compliances as procedural matters that did not involve fraud, financial irregularities or misstatement of the company’s affairs. That representation does not determine the result of the pending independent-director proceeding or a separate March 18, 2026 voluntary disclosure. On that date, SpectraA filed Form GNL-1 regarding discrepancies across filings for FY10 through FY24, and that application was pending approval.

What records and other filings remain unresolved at SpectraA?

SpectraA says certain historical share-transfer forms and gift deeds cannot be traced by the company or its promoters. The unavailable records include gift transfers of 17,666 and 10,000 equity shares dated December 5, 2016, and two Form 7B transfers of 1,666 and 1,667 equity shares dated February 4, 2011. SpectraA reconstructed the transfer details using annual returns, board resolutions and member registers.

SpectraA engaged an independent practising company secretary to search the Ministry of Corporate Affairs portal, with the search report certified on March 18, 2026. SpectraA says it cannot assure that original forms or other records will become available and may not be able to provide information beyond the capital-structure disclosure prepared from alternative records. The limitation concerns the completeness of historic evidence, not a disclosed finding that the transfers were invalid.

The company separately reported the delayed DPT-3 returns for FY19 to FY22 that resulted in the Rs 75,000 compounding payment. Its March 18, 2026 GNL-1 application covered discrepancies in Form 23AC or AOC-4, Form 20B or MGT-7, MGT-14, ADT-1, PAS-6, SH-7 and Form 66 across identified financial years. SpectraA says there is no assurance about the timing or outcome of proceedings, or that future reporting delays or clerical errors will not occur.

Conclusion

SpectraA’s disclosed governance record combines an independent-director requirement triggered by FY23 turnover of Rs 100.31 crore with a pending compounding application, despite the October 4, 2025 appointment of three directors. The disclosure also records 60 delayed ROC forms, a completed Rs 75,000 DPT-3 compounding process and unavailable documents for four identified historic equity-share transfers.

The next disclosed developments to watch are the Regional Director’s decision on the November 24, 2025 independent-director compounding application and approval of the March 18, 2026 GNL-1 voluntary disclosure. SpectraA’s stated response includes a company secretary, a compliance officer and tighter monitoring, but the outcome depends on timely future filings and the resolution of the pending matters.

Frequently Asked Questions

SpectraA says FY23 turnover reached Rs 100.31 crore, triggering the independent-director requirement under Sections 149(4) and 149(5) of the Companies Act, 2013 and related rules. It filed a compounding application on November 24, 2025 for non-appointment of independent directors.

Yes. SpectraA says it appointed three independent directors on October 4, 2025 and filed Form DIR-12 with the Registrar of Companies, Bangalore. The disclosure does not identify the three directors or state when the statutory appointment obligation first became due.

No. SpectraA records its November 24, 2025 application as pending before the Regional Director, South East Region, Hyderabad, through the Registrar of Companies, Bangalore. The October 4, 2025 appointments corrected the disclosed default but did not conclude the compounding proceeding.

SpectraA disclosed 60 delayed statutory forms or returns covering events from July 15, 2010 through November 3, 2025. The company says the identified matters were procedural and did not involve fraud, financial irregularities or misstatement of its affairs.

SpectraA says certain gift deeds and Form 7B transfer forms are not traceable, including records for transfers of 17,666, 10,000, 1,666 and 1,667 equity shares. It reconstructed the transfers using annual returns, board resolutions, member registers and an independent company-secretary search report certified on March 18, 2026.